Literature DB >> 18802683

Disseminated intravascular coagulation score is associated with mortality for children with shock.

Robinder G Khemani1, Robert D Bart, Todd A Alonzo, George Hatzakis, Douglas Hallam, Christopher J L Newth.   

Abstract

OBJECTIVE: To evaluate the association between disseminated intravascular coagulation (DIC) score and mortality for children with shock.
DESIGN: Retrospective.
SETTING: Tertiary care, 20-bed pediatric intensive care unit. PATIENTS: A total of 132 children with sepsis or shock admitted from January 2003 to December 2005. MEASUREMENTS AND
RESULTS: A total of 132 patients less than 18 years of age with a diagnosis of shock or sepsis were included in the analysis. Of these patients, 90 survived and 42 died (31.8%). Patients ranged from 6 days to 18 years (median 5.8 years), and were a majority male (63%). Variables associated with mortality included peak DIC score within 24 h of ICU admission, age, weight, volume of blood products transfused, inotrope score, pediatric index of mortality (PIM 2) score, 12-h pediatric risk of mortality (PRISM III) score and presence of mechanical ventilation (P < 0.05). Patients with DIC scores >or= 5 (overt DIC) had 50% mortality, compared to 20% for patients with DIC scores < 5. Overall, a one-point rise in DIC score was associated with an increased risk of mortality after adjusting for age, race, gender, hemodynamic instability, and PRISM III score [OR 1.35 (1.02, 1.78)]. Most patients achieve their peak DIC score within 2 h of ICU admission.
CONCLUSIONS: This analysis suggests that DIC score, easily calculated early in ICU admission, is associated with mortality for children with sepsis and shock, regardless of initial severity of illness or inotrope use.

Entities:  

Mesh:

Year:  2008        PMID: 18802683     DOI: 10.1007/s00134-008-1280-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  22 in total

1.  Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.

Authors:  F B Taylor; C H Toh; W K Hoots; H Wada; M Levi
Journal:  Thromb Haemost       Date:  2001-11       Impact factor: 5.249

2.  Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit.

Authors:  Kazuhiro Okabayashi; Hideo Wada; Syunsuke Ohta; Hirosi Shiku; Tsutomu Nobori; Kazuo Maruyama
Journal:  Am J Hematol       Date:  2004-07       Impact factor: 10.047

3.  On the evaluation of the ISTH score for overt disseminated intravascular coagulation.

Authors:  Paul N Knöbl
Journal:  Crit Care Med       Date:  2005-05       Impact factor: 7.598

4.  Modified score for disseminated intravascular coagulation in the critically ill.

Authors:  Mirka Sivula; Minna Tallgren; Ville Pettilä
Journal:  Intensive Care Med       Date:  2005-06-15       Impact factor: 17.440

5.  Global fibrinolytic capacity in pediatric patients with sepsis and disseminated intravascular coagulation.

Authors:  Ali Bay; Ahmet Faik Oner; Dogan Kose; Murat Dogan
Journal:  Blood Coagul Fibrinolysis       Date:  2006-10       Impact factor: 1.276

6.  Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery.

Authors:  E B Rosenzweig; T J Starc; J M Chen; S Cullinane; D M Timchak; W M Gersony; D W Landry; M E Galantowicz
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

7.  New disseminated intravascular coagulation score: A useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores.

Authors:  Matthias W A Angstwurm; Carl-Erik Dempfle; Michael Spannagl
Journal:  Crit Care Med       Date:  2006-02       Impact factor: 7.598

8.  PRISM III: an updated Pediatric Risk of Mortality score.

Authors:  M M Pollack; K M Patel; U E Ruttimann
Journal:  Crit Care Med       Date:  1996-05       Impact factor: 7.598

Review 9.  Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock.

Authors:  Joseph A Carcillo; Alan I Fields
Journal:  Crit Care Med       Date:  2002-06       Impact factor: 7.598

10.  A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria.

Authors:  Satoshi Gando; Toshiaki Iba; Yutaka Eguchi; Yasuhiro Ohtomo; Kohji Okamoto; Kazuhide Koseki; Toshihiko Mayumi; Atsuo Murata; Toshiaki Ikeda; Hiroyasu Ishikura; Masashi Ueyama; Hiroshi Ogura; Shigeki Kushimoto; Daizoh Saitoh; Shigeatsu Endo; Shuji Shimazaki
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

View more
  17 in total

1.  Disseminated Intravascular Coagulation Is an Independent Predictor of Adverse Outcomes in Children in the Emergency Department with Suspected Sepsis.

Authors:  Leonora R Slatnick; Dianne Thornhill; Sara J Deakyne Davies; James B Ford; Halden F Scott; Marilyn J Manco-Johnson; Beth Boulden Warren
Journal:  J Pediatr       Date:  2020-06-14       Impact factor: 4.406

2.  Coinfection with Staphylococcus aureus increases risk of severe coagulopathy in critically ill children with influenza A (H1N1) virus infection.

Authors:  Trung Nguyen; Ursula G Kyle; Nancy Jaimon; M Hossein Tcharmtchi; Jorge A Coss-Bu; Fong Lam; Jun Teruya; Laura Loftis
Journal:  Crit Care Med       Date:  2012-12       Impact factor: 7.598

3.  Modulating the rate of fibrin formation and clot structure attenuates microvascular thrombosis in systemic inflammation.

Authors:  Christian Valladolid; Marina Martinez-Vargas; Nitin Sekhar; Fong Lam; Cameron Brown; Timothy Palzkill; Alexander Tischer; Mathew Auton; K Vinod Vijayan; Rolando E Rumbaut; Trung C Nguyen; Miguel A Cruz
Journal:  Blood Adv       Date:  2020-04-14

4.  Pulse oximetry vs. PaO2 metrics in mechanically ventilated children: Berlin definition of ARDS and mortality risk.

Authors:  Robinder G Khemani; Sarah Rubin; Sanjay Belani; Dennis Leung; Simon Erickson; Lincoln S Smith; Jerry J Zimmerman; Christopher J L Newth
Journal:  Intensive Care Med       Date:  2014-09-18       Impact factor: 17.440

5.  A recombinant fragment of von Willebrand factor reduces fibrin-rich microthrombi formation in mice with endotoxemia.

Authors:  Trung C Nguyen; Francisca Gushiken; Juliana I Correa; Jing-Fei Dong; Swapan K Dasgupta; Perumal Thiagarajan; Miguel A Cruz
Journal:  Thromb Res       Date:  2015-03-03       Impact factor: 3.944

Review 6.  Year in review in Intensive Care Medicine 2009. Part III: mechanical ventilation, acute lung injury and respiratory distress syndrome, pediatrics, ethics, and miscellanea.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2010-02-23       Impact factor: 17.440

Review 7.  Thrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury.

Authors:  Trung C Nguyen; Miguel A Cruz; Joseph A Carcillo
Journal:  Crit Care Clin       Date:  2015-08-07       Impact factor: 3.598

8.  Evaluation of the International Society on Thrombosis and Haemostasis and institutional diagnostic criteria of disseminated intravascular coagulation in pediatric patients.

Authors:  Esther P Soundar; Purviben Jariwala; Trung C Nguyen; Karen W Eldin; Jun Teruya
Journal:  Am J Clin Pathol       Date:  2013-06       Impact factor: 2.493

9.  Pediatric Sepsis - Part I: "Children are not small adults!"

Authors:  Derek S Wheeler; Hector R Wong; Basilia Zingarelli
Journal:  Open Inflamm J       Date:  2011-10-07

10.  Evidence of disseminated intravascular coagulation in a hemorrhagic fever with renal syndrome-scoring models and severe illness.

Authors:  Erik Sundberg; Johan Hultdin; Sofie Nilsson; Clas Ahlm
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.